Inpharma Weekly

, Volume 1580, Issue 1, pp 5–5 | Cite as

ACP 103 enhances antipsychotic efficacy, reduces weight gain

Media release
  • 4 Downloads

Keywords

Adverse Event Placebo Clinical Trial Treatment Group Schizophrenia 

Copyright information

© Adis International Ltd 2007

Personalised recommendations